The Novavax vaccine will be produced at the National Research Council of Canada facility on Royalmount Avenue, in Montreal. And as Global’s Felicia Parrillo reports, the announcement is a big step forward in the fight against COVID-19 here at home.
- Novavax seeks WHO approval for emergency listing of COVID-19 vaccine
- Novavax vaccine shows 51% efficacy in COVID-19 infections caused by B.1.351 variant
- Canada invests millions more in domestic drug development to combat COVID-19